Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
9.89
-0.04 (-0.40%)
Jun 11, 2026, 3:04 PM CST
SHE:002923 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| 3,325 | 3,195 | 4,133 | 4,186 | 4,552 | 2,999 | |
Market Cap Growth | -21.00% | -22.69% | -1.28% | -8.03% | 51.79% | -7.11% |
Enterprise Value | 3,667 | 3,515 | 4,502 | 4,526 | 4,553 | 2,821 |
Last Close Price | 9.93 | 9.43 | 11.97 | 11.91 | 12.59 | 8.13 |
PE Ratio | - | 80.11 | 61.77 | 26.93 | 32.57 | 22.07 |
PS Ratio | 2.80 | 2.70 | 3.20 | 3.05 | 3.83 | 2.39 |
PB Ratio | 3.18 | 2.77 | 3.51 | 3.50 | 4.09 | 2.89 |
P/TBV Ratio | 3.38 | 2.94 | 3.71 | 3.71 | 4.36 | 3.08 |
P/FCF Ratio | 47.27 | 24.59 | - | - | - | - |
P/OCF Ratio | 36.61 | 15.13 | 23.93 | 31.01 | 22.11 | 11.98 |
EV/Sales Ratio | 3.08 | 2.97 | 3.49 | 3.30 | 3.83 | 2.25 |
EV/EBITDA Ratio | 30.58 | 20.28 | 24.70 | 19.22 | 22.95 | 13.86 |
EV/EBIT Ratio | - | 88.95 | 63.04 | 27.26 | 32.88 | 18.37 |
EV/FCF Ratio | 52.12 | 27.05 | - | - | - | - |
Debt / Equity Ratio | 0.53 | 0.43 | 0.49 | 0.39 | 0.26 | 0.07 |
Debt / EBITDA Ratio | 4.61 | 2.84 | 3.11 | 1.97 | 1.42 | 0.34 |
Debt / FCF Ratio | 7.86 | 3.85 | - | - | - | - |
Net Debt / Equity Ratio | 0.33 | 0.26 | 0.30 | 0.21 | 0.03 | -0.22 |
Net Debt / EBITDA Ratio | 2.91 | 1.70 | 1.97 | 1.05 | 0.18 | -1.11 |
Net Debt / FCF Ratio | 4.85 | 2.26 | -193.53 | -2.12 | -0.21 | 35.38 |
Asset Turnover | 0.56 | 0.54 | 0.57 | 0.65 | 0.70 | 0.88 |
Inventory Turnover | 1.80 | 1.61 | 1.60 | 1.64 | 1.50 | 1.82 |
Quick Ratio | 0.82 | 0.81 | 0.96 | 0.73 | 1.06 | 1.27 |
Current Ratio | 1.60 | 1.69 | 1.94 | 1.61 | 1.91 | 2.16 |
Return on Equity (ROE) | -4.73% | 3.42% | 5.63% | 13.47% | 13.00% | 13.73% |
Return on Assets (ROA) | -1.00% | 1.12% | 1.98% | 4.95% | 5.06% | 6.76% |
Return on Invested Capital (ROIC) | -2.36% | 2.48% | 3.73% | 11.01% | 13.01% | 19.34% |
Return on Capital Employed (ROCE) | -2.20% | 2.40% | 4.00% | 9.80% | 9.30% | 13.30% |
Earnings Yield | -1.56% | 1.25% | 1.62% | 3.71% | 3.07% | 4.53% |
FCF Yield | 2.12% | 4.07% | -0.04% | -2.79% | -3.75% | -0.21% |
Dividend Yield | 1.51% | 1.59% | 1.67% | 2.10% | 1.75% | 2.71% |
Payout Ratio | - | 212.36% | 153.04% | 57.68% | 59.13% | 56.19% |
Buyback Yield / Dilution | 2.03% | 0.64% | 1.04% | -0.19% | -0.96% | 1.19% |
Total Shareholder Return | 3.54% | 2.23% | 2.71% | 1.91% | 0.78% | 3.89% |